Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immuneering Corporation - Class A Common Stock
(NQ:
IMRX
)
2.000
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
24,199
Open
2.000
Bid (Size)
2.020 (1)
Ask (Size)
2.050 (7)
Prev. Close
2.000
Today's Range
2.000 - 2.000
52wk Range
1.000 - 7.920
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Mastering Market Chaos: StoryTrading’s Top 5 Stocks You Can’t Ignore
December 20, 2024
The trading landscape is alive with opportunity, shaped by a mix of macroeconomic events and sector-specific moves.
Via
Talk Markets
Topics
Stocks / Equities
Immuneering Launches Pancreatic Cancer Advisory Board
December 19, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Performance
YTD
-72.68%
-72.68%
1 Month
-4.76%
-4.76%
3 Month
-30.31%
-30.31%
6 Month
+34.23%
+34.23%
1 Year
-73.26%
-73.26%
More News
Read More
Top Trade Picks Of The Day: Don’t Miss These Market Movers
December 17, 2024
Via
Talk Markets
Topics
Stocks / Equities
Immuneering to Present Data from Three Arms of its Ongoing Phase 2a Trial of IMM-1-104 in Early January 2025
December 17, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Why is Immuneering (IMRX) Stock Up 24% Today?
August 01, 2024
Via
InvestorPlace
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?
December 13, 2024
Via
Benzinga
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma
December 12, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
November 27, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 13, 2024
From
Immuneering Corporation
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
October 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 15, 2024
Via
Benzinga
Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
October 15, 2024
From
Immuneering Corporation
Via
GlobeNewswire
EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In September 2024 – Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
October 02, 2024
Via
Benzinga
Why Is Nanocap Immuneering Stock Trading Higher On Friday?
September 13, 2024
Via
Benzinga
Immuneering Announces Positive Initial Phase 2a Data Including Complete and Partial Responses with IMM-1-104 in Combination with Chemotherapy in First-Line Pancreatic Cancer Patients
September 12, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
August 29, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 06, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Nasdaq Surges 1%; Meta Posts Upbeat Earnings
August 01, 2024
Via
Benzinga
Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
August 01, 2024
Via
Benzinga
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in First-line Pancreatic Cancer
July 31, 2024
From
Immuneering Corporation
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 11, 2024
Via
Benzinga
Immuneering to Present at the Jefferies Global Healthcare Conference
May 29, 2024
From
Immuneering Corporation
Via
GlobeNewswire
IMRX Stock Earnings: Immuneering Misses EPS for Q1 2024
May 07, 2024
Via
InvestorPlace
Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
May 07, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Immuneering Recognizes Melanoma Awareness Month
May 06, 2024
From
Immuneering Corporation
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.